Tech Company Financing Transactions
Anacor Pharmaceuticals Funding Round
On 5/11/2005, Anacor Pharmaceuticals raised $25 million in Series C investment from Venrock, Aberdare Ventures and Red Abbey Venture Partners.
Transaction Overview
Company Name
Announced On
5/11/2005
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors
Proceeds Purpose
Anacor is targeting promising markets through the development of new therapeutics for specific dermatological disorders.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1020 East Meadow Cir.
Palo Alto, CA 94303
USA
Palo Alto, CA 94303
USA
Phone
Website
Email Address
Overview
Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/11/2005: Cellerant Therapeutics venture capital transaction
Next: 5/11/2005: CyOptics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs